共 32 条
[1]
Mikawa K., Nishina K., Maekawa N., Obara H., Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation, Br. J. Anaesth, 76, pp. 221-226, (1996)
[2]
Grossman E., Messerli F.H., Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure, Am. J. Cardiol, 80, pp. 1453-1458, (1997)
[3]
Conrad K.A., Fagan T.C., Mayshar P., Davis T.P., Johnson D.G., Antihypertensive effects of parenteral nicardipine alone and in combination with captopril, Clin. Pharmacol. Ther, 42, pp. 113-118, (1987)
[4]
Ryman K.S., Kubo S.H., Shaknovich A., Cody R.J., Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure, Clin. Pharmacol. Ther, 41, pp. 483-489, (1987)
[5]
Amodeo C., Kobrin I., Ventura H.O., Messerli F.H., Frohlich E.D., Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension, Circulation, 73, pp. 108-113, (1986)
[6]
Yeung P.K., Hung O.R., Pollak P.T., Klassen G.A., Pharmacokinetics and hemodynamic effects of diltiazem in healthy volunteers: Comparing resting with the effects of exercise, Int. J. Clin. Pharmacol. Ther, 37, pp. 413-416, (1999)
[7]
Heart rate variability: Standards of measurements, physiological interpretation, and clinical use, Circulation, 93, pp. 1043-1065, (1996)
[8]
Bekheit S., Tangella M., el-Sakr A., Rasheed Q., Craelius W., el-Sherif N., Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction, Am. Heart J, 119, pp. 79-85, (1990)
[9]
Yamasaki F., Sato T., Sugimoto K., Takata J., Chikamori T., Sasaki M., Doi Y., Effect of diltiazem on sympathetic hyperactivity in patients with vasospastic angina as assessed by spectral analysis of arterial pressure and heart rate variability, Am. J. Cardiol, 81, pp. 137-140, (1998)
[10]
Frey A.W., Muller C., Dambacher M., Theisen K., Increased vagal activity after administration of the calcium antagonist diltiazem in patients with coronary heart disease, Z. Kardiol, 84, pp. 105-111, (1995)

